Replies to post #245 on Emisphere Technologies Inc. (fka EMIS)

[MR 1955 DOUBLE DIE]

Did you read this from 9/17 pr?


Mr. Rubino commented, "I was attracted to Emisphere by the broad potential of its Eligen® Technology to improve therapeutic delivery of vital pharmaceutical products and the Company's goal to pursue an IMMEDIATE COMMERCIAL OPPORTUNITY to create value by launching its market-ready Eligen® Oral B12 product."